TrinityPoint Wealth’s iShares Biotechnology ETF IBB Stock Holding History

TrinityPoint Wealth’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$750K	Sell	5,676 -100	-2%	-$14.1K	0.11%	182
2024 Q3	$841K	Buy	5,776 +1	+0%	+$145	0.12%	167
2024 Q2	$793K	Sell	5,775 -113	-2%	-$15.1K	0.12%	165
2024 Q1	$808K	Sell	5,888 -13	-0.2%	-$1.77K	0.13%	156
2023 Q4	$802K	Sell	5,901 -319	-5%	-$38.9K	0.15%	145
2023 Q3	$761K	Sell	6,220 -113	-2%	-$14.4K	0.15%	139
2023 Q2	$804K	Buy	6,333 +3,640	+135%	+$473K	0.16%	132
2023 Q1	$348K	Sell	2,693 -8	-0.3%	-$1.05K	0.07%	204
2022 Q4	$355K	Buy	2,701 +235	+10%	+$30.4K	0.08%	201
2022 Q3	$288K	Hold	2,466	–	–	0.07%	210
2022 Q2	$290K	Sell	2,466 -632	-20%	-$75K	0.06%	216
2022 Q1	$404K	Hold	3,098	–	–	0.07%	207
2021 Q4	$473K	Hold	3,098	–	–	0.08%	191
2021 Q3	$501K	Buy	+3,098	New	+$521K	0.1%	182
2021 Q1	–	Sell	-1,214	Closed	-$200K	–	250
2020 Q4	$200K	Buy	+1,214	New	+$173K	0.05%	223

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TrinityPoint Wealth's IBB Position: Q4 2024 in Review

TrinityPoint Wealth reduced its iShares Biotechnology ETF (IBB) stake by 1.7% in Q4 2024, selling an estimated $14.1K and leaving 5,676 shares worth $750K. The position accounts for 0.11% of the portfolio, ranked #182.

TrinityPoint Wealth first reported a position in IBB in Q4 2020 and has held it in 15 quarters since. The position peaked at $841K in Q3 2024. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

TrinityPoint Wealth held 5,676 shares of iShares Biotechnology ETF worth $750K as of Q4 2024.
TrinityPoint Wealth sold 100 iShares Biotechnology ETF shares in Q4 2024, an estimated $14.1K.
iShares Biotechnology ETF made up 0.11% of TrinityPoint Wealth's portfolio in Q4 2024, its #182 holding.
TrinityPoint Wealth first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 15 quarters since.
TrinityPoint Wealth's iShares Biotechnology ETF position peaked at $841K in Q3 2024.
874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on TrinityPoint Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.